Factor XII Test (Hageman Factor Assay) measures the activity of a vital blood-clotting protein to detect any deficiency or abnormality in the coagulation process. Available at
Factor XII, also known as Hageman factor, is a key protein in the blood coagulation process that helps initiate clot formation. The Factor XII test (Factor XII assay) is performed to measure the activity or concentration of this particular clotting factor in your blood. This test helps identify abnormalities related to unusual bleeding or thrombosis (blood clots).
In normal conditions, Factor XII activates other clotting factors to ensure proper hemostasis. Low levels can indicate a rare Factor XII deficiency, which may prolong clotting time but typically does not cause severe bleeding. However, abnormal activity can also relate to conditions such as liver disease, inherited disorders, or certain autoimmune reactions. At Diagnopein, our advanced laboratory systems measure Factor XII levels precisely to support accurate diagnostic outcomes.
The Factor XII test plays a crucial role in evaluating the blood’s clotting ability and diagnosing potential abnormalities in the coagulation cascade. Understanding Factor XII levels provides insight into both bleeding and thrombotic tendencies.
Here’s why this test is important:
It helps detect Factor XII deficiency, a condition that can lead to prolonged activated partial thromboplastin time (aPTT).
It supports differential diagnosis in patients with unexpectedly long coagulation times but without major bleeding history.
It assists doctors in managing liver disorders, disseminated intravascular coagulation (DIC), or autoimmune conditions.
It contributes valuable data for pre-surgical assessments or in patients with recurrent pregnancy loss.
Timely evaluation of Factor XII through Diagnopein’s advanced assay system ensures accurate correlation with other coagulation factors for complete interpretation.
The Factor XII assay test is performed using a blood sample, usually drawn from a vein in the arm. The process is quick, minimally invasive, and requires no special preparation unless advised by the doctor.
Testing parameters include:
Factor XII activity (expressed as a percentage)
Activated Partial Thromboplastin Time (aPTT)
Coagulation profile comparison
Interpretation with other clotting factor assays
At Diagnopein, our collection and testing procedures follow strict clinical standards. Samples are analyzed using automated coagulation analyzers that provide precise Factor XII activity readings. Once analyzed, the report helps the physician identify whether the activity level falls within the expected reference range or indicates any underlying deficiency or disorder.
If results show low Factor XII levels, it does not necessarily increase bleeding risk. Instead, it may be associated with certain genetic traits or mild clotting abnormalities. In contrast, elevated Factor XII levels may be linked to higher clotting tendencies or inflammation.
A Factor XII test is highly beneficial in clinical diagnosis and preventive health evaluations. By identifying abnormalities early, physicians can tailor treatment strategies for optimal care outcomes.
Benefits of Factor XII testing:
Helps in identifying hereditary or acquired deficiencies
Guides treatment for coagulation-related disorders
Provides important data before major surgeries
Assists in comprehensive thrombophilia evaluation
Enhances understanding of unexplained coagulation results
In specialized clinical settings, Factor XII assays also contribute to research, genetic counseling, and complex coagulation investigations. Accurate results help clinicians design personalized management plans and avoid unnecessary treatments, especially when prolonged clotting time is observed with no clinical bleeding symptoms.
Diagnopein combines precision diagnostics, advanced coagulation testing technology, and patient-centered care. Our laboratory follows rigorous quality standards and adopts modern analytic systems to ensure dependable, reproducible outcomes for every Factor XII test.
Reasons to choose Diagnopein:
High-precision coagulation analyzers
Expert hematology and pathology team
Fast and accurate reporting
Affordable test pricing
Easy online booking and report access
With a focus on quality and accuracy, Diagnopein remains a trusted partner for hospitals, clinics, and patients needing detailed Factor XII activity assessments.
A healthcare professional will draw a blood sample from a vein in your arm. The blood is then sent to a laboratory for analysis to measure the activity of Factor XII using various assays.
The test is performed to evaluate bleeding disorders, monitor patients on anticoagulant therapy, assess thrombotic risks, and investigate unexplained bleeding or clotting tendencies.
The test involves a standard blood draw, which carries minimal risks, such as bruising, bleeding, or infection at the needle site. Overall, it is considered a safe procedure.
Generally, no special preparation is required. However, you should inform your healthcare provider of any medications you are taking, as some anticoagulants may affect the factor XII test results.